Corporate Assignee
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Corporate Assignee
active
No affiliations
2,4-dioxo-3-quinazolinylaryl sulfonylureas
Inhibitors of syk and JAK protein kinases
Methods of identifying agents that modulate P2Y12 receptor...
Methods of treatment with Syk inhibitors
Platelet ADP receptor inhibitors
LandOfFree
Portola Pharmaceuticals Inc. does not yet have a rating. At this time, there are no reviews or comments for this inventor.
If you have personal experience with Portola Pharmaceuticals Inc., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Portola Pharmaceuticals Inc. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-P-3002439